chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The night of injection, arm/neck given injection were sore. Overnight, became feverish with chills and nausea. During one trip to bathroom where bladder was drained, felt nauseated and light-headed. Got into position to vomit into toilet, and upon getting up, fainted. Spent the rest of the day with high levels of nausea, soreness, and headaches. At the end of the day, with more ibuprophen and pepto bismol, was able to sit up and interact. Food body would accept without nausea was crackers/toast. At end of the night, left shoulder was swollen and red around injection site, radiating out approximately 4in.
Patient called to report ongoing arm pain, particularly with abduction. I advised her to follow up with MD. She saw Dr. and was given prednisone and meloxicam. Patient refused physical therapy but was given paperwork with exercises to do and asked to come back in 2 weeks. Patient states she will go back in 1 month and we have asked her to follow up with us after her appointment as well.
Information has been received from the registered nurse. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who on 11-MAR-2013 was administered a dose of GARDASIL (lot # H011350 and expiration date 21-FEB-2015) that was exposed to temperature of 11 Celsius degree. No adverse effects were reported. This is one of several reports from the same source. Additional information is not expected.
@ apprx 1315 patient started feeling heartbeat beating fast, then racing. States she felt hot, dizzy, ears were ringing-the ringing resolved upon being seated. Patient was given 25 mg liquid diphenhydramine (and seated with legs elevated- back of exam table elevated to an approx. 60 degree angle). HR 109, BP 144/87, afebrile, o2 sat 100% on room air.
Arm redness, warmth, swelling 17 x 14 cm 2 days post injection
In March 1999, the pt developed a rash. It was noted that in April 1999, the pt's already sore shoulder progressed to a frozen shoulder. The physician indicated that he is not sure which manufacturer's product the pt received.
Information has been received from a health professional and a  physician concerning an 11 year old female student, with no allergies and a heart murmur and a history of bronchitis, who on 10/09/1995 was vaccinated with a SQ first dose of in the arm of varicella virus vaccine. There was no illness at the time of vaccination and there were no concomitant medications. The pt developed clinical varicella of a mild uncomplicated nature, for which she was seen on 11/09/2004. Benadryl and calamine lotion were prescribed. It was reported that no laboratory or diagnostic tests were performed. Subsequently, the pt recovered. No product quality complaint was involved. Additional infomation is not expected.
Information received from 45 year old female physician who booster dose of hepatitis B for "waning immunity." Within 2 hours of vax, the pt experienced dizziness, lightheadedness and nausea. No further information is available.
Chills; Fatigue; Muscle aches; Lack of appetite; Fever; This is a spontaneous report from a non-contactable consumer, the patient. A 65-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER- BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration in the left arm on 05Mar2021 at 09:15 (at the age of 65-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER- BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9266), via an unspecified route of administration in the left arm on 12Feb2021 at 11:30, as a single dose for COVID-19 immunisation. The patient experienced chills, fatigue, muscle aches, lack of appetite and fever on 06Mar2021 at 01:00. The patient did not receive any treatment for the events. The clinical outcome of the events chills, fatigue, muscle aches, appetite lost and fever was resolved on an unknown date in Mar2021.   No follow-up attempts are possible. No further information is expected.
Monday, 4/12 - Had first-ever (in my life) nosebleed; painful shingles rash emerged on right shoulder blade Tuesday, 4/13 - Had second-ever nosebleed; shingles rash painful + itchy Thursday, 4/15 - Went to urgent care thinking that shingles rash was spider bite; urgent care doc visually examined and confirmed it was shingles, prescribed Valtrex; went to primary care doc who confirmed shingles and took blood to test platelets Friday, 4/16 - Blood test confirmed platelets are normal Saturday, 4/17 - Had third nosebleed
Subcutaneous nodule, associated with warmth and pain developed in injection side approx 48 hours after vaccine.   Nodule is persisting
The injection site pain in my shoulder came on after about 4 hours, just as it did with dose 1. However, the pain intensified well past the level of pain that I experienced after the 1st dose. It made sleep difficult that night. I got up the next day, with a lot of pain in my shoulder, I felt very tired but attributed that to the fitful sleep the night before. However, by about 8:30am (about 3 hours after getting up), I felt worse. My neck, shoulder and upper back felt like as though they were mistreated with a baseball bat. I felt extremely tired, to the point that all I could do was lay down. My eyes were burning. By about 10am my head felt really hot but I had no fever. I took my temperature about every hour and never had a fever. By noon I felt no improvements and decided to take Tylenol. Within 45 minutes of taking it I felt completely normal and well. By the end of the day, even the pain in the injection site was gone.
incorrect product storage; No additional adverse effect reported; This spontaneous report recibed from a nurse practitioner refers to a patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not provided.     On an unknown date, the patient was vaccinated with improperly stored doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) lot # S039316 expiration date 04-DEC-2021 for prophylaxis (strength, dose and route were not provided).  No additional adverse effect was reported.  Digital Data Logger registered a temperature excursion between 47 to 77 Fahrennheit degrees (47.7) for 20 minutes.  This is one of several reports received from the same source.; Sender's Comments:  US-009507513-2104USA002701:
24 hours after vaccine, severe diarrhea. 2 days after vaccine,  severe stomach cramps for 5 days. 8 days after vaccine, red rash started on hands and feet. continued and 4 days later it spread to arms and legs. went to urgent care and was prescribed a steroid. these symptoms are current and ongoing.
approximately 1100 1-20-08 given smallpox immunization w/o authorization by provider and with dx of eczema.
A physician described the occurrence of aseptic meningitis in a 29 year old male who was vaccinated with hepatitis A vaccine inactivated (Havrix) for prophylaxis. The subject's medical history and concurrent conditions were unknown. Havrix was the only new medication/vaccine given to the patient recently. Approximately the beginning of January 2003, the subject received an injection of Havrix; it was not known if he had received previous injections of Havrix. Ten days or less post-immunization, the physician made a diagnosis of aseptic meningitis. The subject was hospitalized for an unspecified period of time. As of 1/10/03, the outcome of the event was unknown.
No Adverse Event Incorrect spacing between doses.  2nd dose was given 5/1/21 and 3rd dose was given 10/4/21.  Should have been spaced 6months but was only spaced 5 months.
Pt reported she had just finished her menses at the end of June and was not pregnant and using condoms for birth control. Pt was educated to avoid pregnancy for 3 months. Client returned to clinic on 7/25/00 with complaint of post threat amenorrhea, some nausea by meals. Pt saw FNP for follow-up care
01Aug2021 she took him to be tested and he tested positive for COVID-19; This is a spontaneous report from a contactable consumer (patient' mother). A 19-year-old male patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Jul2021, as single dose (Batch/Lot number was not reported) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was tested positive for COVID-19 on 01Aug2021 and he was due for the second dose on 11Aug2021. The reporter would like to know if it was possible the vaccine was still in him and was causing a false positive result. The outcome of event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Patient had third Pfizer/BioNtech vaccine within the past 2 weeks.; Patient had third Pfizer/BioNtech vaccine within the past 2 weeks.; Tested positive for COVID; Tested positive for COVID; This is a spontaneous report from a contactable consumer.   A 72-year-old male patient received three doses of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date, at the age of 72-years-old,  (Batchs/Lot numbers was not reported) as single dose for covid-19 immunisation. Medical history included chronic kidney disease and renal transplant from an unknown date. The patient received other unspecified medications. The patient tested positive for covid via Nasal Swab on 07Sep2021. The patient received Monoclonal Antibody Infusion as treatment for the event. No covid prior vaccination and no covid tested post vaccination. The outcome of the event was not recovered.  The lot number for the vaccine, bnt162b2 was not provided and will be requested during follow up.
This case was reported by a other health professional via call center representative and described the occurrence of therapy non-responder in a male patient who received Hepatitis B vaccine. Previously administered products included Hepatitis B vaccine (2 full series). On an unknown date, the patient received Hepatitis B vaccine at an unknown dose. On an unknown date, an unknown time after receiving Hepatitis B vaccine, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was not recovered/not resolved. It was unknown if the reporter considered the therapy non-responder to be related to Hepatitis B vaccine. Additional information: a doctor did not respond to receipt of 2 full series' of Hepatitis B vaccine. The blood work was pulled 1-2 months after each series as recommended.
Hepatitis B vaccine caused yellowing of the skin and eyes, lethargic. Would not eat. Begin formula feeding with breast milk for two days with syringe and lots of daylight on skin. Begin improving after four days.
Patient was given MMR vaccine on 1/18/08.  Started with body aches on 1/22/08.  Joint aches/Arthralgias on 1/23/08.
This spontaneous report as received from a nurse practitioner refers to a 13 months old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. On 26-JAN-2015, the patient was vaccinated with the dose of PEDVAXHIB lot # K008874 (dose, strength, route of administration and expiration date were not reported) which had temperature excursion. No information on patient's concomitant medication was provided. No adverse events were experienced. This is one of several reports from the same reporter. Additional information has been requested.
Arm pain around shot, chills, fever, muscle ache in entire body. Arm pain lasted approximately 48 hrs. Chills and fever lasted about 12 hrs, muscle ache lasted about 24 hours. No treatment.
Patient experienced high fever (101 degrees) starting at 4AM 7-23-16 and a severe headache. Injection site is swollen and red.
Information has been received from a health care worker concerning a 77 year old female with cholesterol, acid reflux, an unspecified "heart condition" and no allergies reported.  On 13-JUN-2005 the patient was vaccinated with the first dose of pneumococcal 23v vaccine (lot 647661-0055R).  Concomitant therapy included esomeprazole magnesium (NEXIUM), atorvastin calcium (LIPITOR) clopidogrel bisulfate (PLAVIX) and aspirin.  On 14-JUN-2005 the patient developed redness, swelling an burning of injection site area.  The patient sought unspecified medical attention.  The events subsided in a few days with no treatment required.  The patient was noted to be recovering.  Additional information has been requested.
Hives, rash, itching, coughing, sneezing.  Discussed with nurse and doctor at State Department Immunization Center by telephone.  Visited personal physician.
Flu-like symptoms, chills, fever 101, sweating, fatigue, dizziness, lightheaded. Lasted about 24 hours from onset, then fatigue, tiredness and clammy for 24 hours
Terrible chills, high fever that wouldn't go down all night and day, headache, nausea, fatigue.
Information has been received from a medical assistant concerning a 5 year old patient who on 19-JUL-2004 was vaccinated with VARIVAX (Oka/Merck). On 14-AUG-2006 the patient developed chickenpox. Subsequently the patient recovered from the chicken pox. The patient was given a second dose of 29-JAN-2008. Additional information has been requested.
12/29 vaccine. 10 minutes later throat tightening, SOB; anaphylactic symptoms. Administered benadryl. Monitored 30 minutes. sent home.
On the afternoon of Sunday, July 30, my daughter came down with a fever that ranged from 99 to 101 and lasted for 48 hours. She had low energy, lazed around a lot - when she is normally very active, and her appetite was low. I asked a parent group I am in if the fever could be a reaction to her DTaP even though it was almost two weeks after. The resounding response was YES! And more than one person said to report it to VAERS.
Body cramps and spasms in feet, legs, hands, back, and neck. Post menopausal bleeding.
No adverse event; Received 0.25 ml dose instead of 0.5 ml for Bivalent Booster; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Received 0.25 ml dose instead of 0.5 ml for Bivalent Booster) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 12-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Received 0.25 ml dose instead of 0.5 ml for Bivalent Booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Received 0.25 ml dose instead of 0.5 ml for Bivalent Booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Received 0.25 ml dose instead of 0.5 ml for Bivalent Booster).    No concomitant medication details was reported. That case contains information for the 8th of 15 adult patients described by the reporter. No treatment medication details was reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-658139, US-MODERNATX, INC.-MOD-2022-658159, US-MODERNATX, INC.-MOD-2022-658149, US-MODERNATX, INC.-MOD-2022-658161, US-MODERNATX, INC.-MOD-2022-658162, US-MODERNATX, INC.-MOD-2022-658154 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-658159:Adult patient 8 US-MODERNATX, INC.-MOD-2022-658139:Adult patient 8 US-MODERNATX, INC.-MOD-2022-658162:Adult patient 8 US-MODERNATX, INC.-MOD-2022-658161:Adult patient 8 US-MODERNATX, INC.-MOD-2022-658149:Adult patient 8 US-MODERNATX, INC.-MOD-2022-658154:Adult patient 8
pt received 1st pfizer covid vaccination and within 5 min had passed out. pt was passed out for about 4 seconds. i placed pt on the floor from the bench and elevated his legs and rubbed his sternum gently until the pt regained color and consciousness. i asked for a wet towel and bottle of water for the pt to help him feel better. watched the pt for an extended period of time (>30min) to make sure he was feeling ok before letting him go. told the mother to make sure to watch him closely the rest of the night.
Stroke; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), outcome "unknown", described as "Stroke". The patient underwent the following laboratory tests and procedures: Blood cholesterol: 139.  Clinical course: Reporter stated I just want you to know that my husband suffered a stroke and I'm coming after you ! I'm filling a lawsuit against pfizer for this vaccine you made! I'm not going to give up till the public knows your vaccines are causing strokes and heart attacks. The dr even said to us that it was the vaccine. My husband is super healthy, cholesterol of 139 . Works out everyday. Shame on you , you will pay for this. See you in court.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
while waiting the 15 minutes after receiving the vaccine, the patient became nauseous, faint, sweaty and vomited.  She remained sitting and was given cold compresses that she used on her neck, face and hands.  After 15 minutes,  all symptoms had resolved and she felt back to normal.
This spontaneous report as received from a physician via a company representative, refers to a male patient of unknown age. The patient's concurrent conditions, drug reactions/allergies and medical history were not reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX 19400 plaque forming unit (PFU) (dose, route of administration, lot number and expiration date were unknown). There were no concomitant therapies reported. The reporter stated that then, on an unknown amount of time, the patient developed shingles. No product quality complaint was involved. The outcome of herpes zoster was unknown. The causality between herpes zoster and ZOSTAVAX was not provided. Additional information is not expected because no permission to contact the physician was provided.
6 hrs after HepA vaccine (2nd dose) had 15-20 sec. of tonic/clonic seizure activity. No fever. Lethargic for about 15 min then came back to normal. Normal exam in office 4 hrs. later. No history of seizures.
pt recvd vax;26nov started w/ arthralgia,macular rash over trunk; adenopathy,lasted 7-10 days;appearance of rubella;
Vaccine was stored on refrigerator on 22-Aug-2022 and vaccine was administered on 23-Sep-2022; No adverse event; Patient given vaccine after BUD date, expire beyond date 22-Sep-2022, vaccine administered 23-Sep-2022; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient given vaccine after BUD date, expire beyond date 22-Sep-2022, vaccine administered 23-Sep-2022), PRODUCT STORAGE ERROR (Vaccine was stored on refrigerator on 22-Aug-2022 and vaccine was administered on 23-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 2-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. AR9237B and AR9237B) for COVID-19 prophylaxis.     No Medical History information was reported.   On 12-Aug-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Sep-2022 at 4:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 23-Sep-2022 at 4:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient given vaccine after BUD date, expire beyond date 22-Sep-2022, vaccine administered 23-Sep-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored on refrigerator on 22-Aug-2022 and vaccine was administered on 23-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient given vaccine after BUD date, expire beyond date 22-Sep-2022, vaccine administered 23-Sep-2022), PRODUCT STORAGE ERROR (Vaccine was stored on refrigerator on 22-Aug-2022 and vaccine was administered on 23-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient given vaccine after BUD date, expire beyond date 22-Sep-2022, vaccine administered 23-Sep-2022) and PRODUCT STORAGE ERROR (Vaccine was stored on refrigerator on 22-Aug-2022 and vaccine was administered on 23-Sep-2022).    No concomitant medication was reported.  Vaccine coordinator was calling to report that some patients received expired Moderna COVID-19 vaccine after 30 days beyond use date (22-Sep-2022).  There were unbroken cartons. Vial size for 6 months to 5 years.  The vial did not undergo any temperature excursions.  No treatment information was provided.
Patient had a episode of Tachycardia that lasted about 5 - 10 minutes with the feeling of her head beating out of her chest.   once we got her heart rate to go down she had a pinching sensation above her heart below her clavicle. which lasted about 30 seconds.  This occurred 3 more times.
Headache Narrative: Tender at injection site, headache, off, and, on, as well as, rib cage and back ache.
Woke up Monday AM with serious muscle and joint pain. By brkfst threw up then again around 1:00 PM. Diarrhea thru out day and flu like symptoms. Fine next day.
Shot given 9-29-09 at 17:00.  Mom called morning of 9-30-09 to report child had fever of 102 & would not walk.  She did not notice legs to be swollen.  She gave TYLENOL alt with Ibuprofen through the day.  Then 10-1-09 she was seen in clinic for fever 102 & not walk.  PPV leg site swollen.  She got fluids & MORPHINE for pain & ROCEPHIN.  She went home & temp was 104 at 17:00.  At 03:00 10.2 She woke up & wanted to eat.  She did not have a fever & started to walk.
Persistant hiccups beginning 1 week post vaccine. Still ongoing. Affecting his diet and sleep -- occuring 24/7
Around 2/22, I began experiencing joint pain and stiffness. Around 2/26 I started feeling very crummy. I needed more sleep, I was very fatigued. I was barely making it through the work day. That continued for another week but then began getting worse. The low energy and tiredness got significantly worse the week of 3/8. It had gotten to a point that I was starting to miss work. Also, I had menstrual spotting that started right around the date of vaccination. This lasted about 3 weeks. It lasted from about 2/22-3/12. I was taking ibuprofen and a topical patch (salonpas) for the joint pain. This helped a little.